학술논문

Sub-myeloablative Second Transplantations with Haploidentical Donors and Post-Transplant Cyclophosphamide have limited Anti-Leukemic Effects in Pediatric Patients
Document Type
Article
Source
In: Transplantation and Cellular Therapy. (Transplantation and Cellular Therapy, May 2022, 28(5):262.e1-262.e10)
Subject
Language
English
ISSN
26666367